Premium
Re: The average Adjusted Symptom Score, a new primary efficacy end‐point for specific allergen immunotherapy trials
Author(s) -
Valenti D.
Publication year - 2012
Publication title -
clinical and experimental allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 154
eISSN - 1365-2222
pISSN - 0954-7894
DOI - 10.1111/j.1365-2222.2012.03989.x
Subject(s) - medicine , clinical trial , citation , immunotherapy , end point , guideline , clinical endpoint , family medicine , library science , computer science , pathology , cancer , real time computing